Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologic Progression”

512 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 512 results

Not applicableEnrolling By InvitationNCT02270567
What this trial is testing

RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

Who this might be right for
Neuroendocrine TumorCarcinoidNeuroendocrine Carcinoma
Wren Laboratories LLC 400
Not applicableNot Yet RecruitingNCT04827290
What this trial is testing

Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease

Who this might be right for
Kidney Failure, ChronicChronic Kidney Disease stage3Chronic Kidney Disease Stage 3B+3 more
Centre Hospitalier Saint Joseph Saint Luc de Lyon 66
Testing effectiveness (Phase 2)Ended earlyNCT03729297
What this trial is testing

Cabozantinib in Advanced Salivary Gland Cancer Patients

Who this might be right for
Salivary Gland Cancer
Radboud University Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT05455424
What this trial is testing

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University Hospital Southampton NHS Foundation Trust 88
Not applicableActive Not RecruitingNCT03728842
What this trial is testing

Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma

Who this might be right for
Melanoma; Renal Cell Carcinoma
Indiana University 19
Early research (Phase 1)Study completedNCT01471067
What this trial is testing

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma+2 more
M.D. Anderson Cancer Center 33
Early research (Phase 1)Looking for participantsNCT06624371
What this trial is testing

Atovaquone Combined With Radiation in Children With Malignant Brain Tumors

Who this might be right for
High-grade GliomaMedulloblastomaDiffuse Intrinsic Pontine Glioma+1 more
Emory University 18
Testing effectiveness (Phase 2)Looking for participantsNCT05528458
What this trial is testing

Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma
Samsung Medical Center 59
Testing effectiveness (Phase 2)Temporarily pausedNCT02008019
What this trial is testing

A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas

Who this might be right for
Chondrosarcoma
Centre Leon Berard 57
Not applicableLooking for participantsNCT06215495
What this trial is testing

A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial

Who this might be right for
Radiation ToxicityMRI Simulated PositioningHigh Grade Glioma+2 more
Zhujiang Hospital 88
Testing effectiveness (Phase 2)Ended earlyNCT00052598
What this trial is testing

Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+12 more
Fred Hutchinson Cancer Center 7
Testing effectiveness (Phase 2)UnknownNCT02912754
What this trial is testing

Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Sunnybrook Health Sciences Centre 36
Testing effectiveness (Phase 2)Looking for participantsNCT07043972
What this trial is testing

Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Fox Chase Cancer Center 55
Not applicableLooking for participantsNCT00280202
What this trial is testing

Detection of Genetic Markers of Lung Cancer

Who this might be right for
Lung Cancer
University of Pittsburgh 6,000
Testing effectiveness (Phase 2)Looking for participantsNCT04933669
What this trial is testing

Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors

Who this might be right for
Progression-free SurvivalGastrointestinal Stromal TumorNeoadjuvant
First Affiliated Hospital of Zhejiang University 122
Testing effectiveness (Phase 2)Study completedNCT01110668
What this trial is testing

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor
Novartis Pharmaceuticals 2
Not applicableActive Not RecruitingNCT07075939
What this trial is testing

Centralization and Oncologic Outcomes in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerOvarian NeoplasmsAdvanced Ovarian Cancer
Azienda USL Reggio Emilia - IRCCS 200
Testing effectiveness (Phase 2)WithdrawnNCT06839872
What this trial is testing

Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
AstraZeneca
Testing effectiveness (Phase 2)Ended earlyNCT03411031
What this trial is testing

Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 18
Large-scale testing (Phase 3)UnknownNCT01134484
What this trial is testing

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Michele Cavo 480
Load More Results